Xilio Therapeutics, Inc. (XLO) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $518.0K | +1338.9% |
| 2024 | $36.0K | -92.6% |
| 2023 | $486.0K | -74.0% |
| 2022 | $1.87M | +69.7% |
| 2021 | $1.10M | -49.7% |
| 2020 | $2.19M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $518.0K | +1338.9% |
| 2024 | $36.0K | -92.6% |
| 2023 | $486.0K | -74.0% |
| 2022 | $1.87M | +69.7% |
| 2021 | $1.10M | -49.7% |
| 2020 | $2.19M | — |